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ABSTRACT 
 
Many pathogenic bacteria use their iron acquisition mechanisms to live inside hosts. 
Streptococcus pyogenes is a pathogenic bacterium that uses streptococcal iron acquisition ABC 
transporter to obtain heme. SiaA (HtsA, spy1795), a lipoprotein located on the cell surface, 
serves as a heme binding protein. To understand the iron-uptake mechanism, histidine 229, one 
of the two proposed axial ligands in SiaA, was mutated to alanine. SiaA H229A was expressed in 
E. coli, lysed by French Press, and purified by fast protein liquid chromatography (FPLC).  SDS-
PAGE indicated that pure protein was isolated.  Nickel affinity FPLC gave purer H229A when 
0.5 M imidazole was added to the binding buffer.  Overall, histidine 229 is likely to be an axial 
ligand in wild type SiaA, as shown by the fact the mutant readily lost heme as evidenced by UV-
vis spectra. 
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Introduction 
Many pathogenic microorganisms use iron acquisition mechanisms to obtain 
heme.  Heme is an essential iron source for many bacteria  (Crosa et al., 2004).  An 
understanding of the structure and mechanism of the iron uptake pathways may help in 
the design agents to control these pathways, possibly resulting in new clinical agents to 
treat disease.   
S. pyogenes uses SiaABC to acquire heme from its host.  SiaA, a heme binding 
protein, is a lipoprotein located on the cell surface. We have proposed that methionine 79 
and histidine 229 are the two axial ligands of the heme.  In this project, histidine 229 was 
studied.  The native ligand, in wild type SiaA, His229, was mutated by replacing histidine 
with alanine (H229A).  H229A SiaA was expressed, purified, and studied. 
 
Streptococcus pyogenes.  Streptococcus pyogenes (Group A Streptococcus) is a Gram-
positive, non-motile, non-spore-forming coccus (Bates et al., 2005; Bates et al., 2003; Liu 
& Lei, 2005).  It is a facultative anaerobe.  S. pyogenes has a capsule composed of 
hyaluronic acid and exhibits beta (clear) hemolysis on blood agar  (Cunningham, 2000).  
It can colonize the respiratory tract, bloodstream, and the skin.  It causes severe infections 
such as pharyngitis (strep throat), toxic shock syndrome, necrotizing fasciitis (flesh eating 
bacteria), and rheumatic fever.   
S. pyogenes exhibits iron-dependent growth  (Eichenbaum et al., 1996b).  Iron 
limitation leads to the induction of genes encoding a putative iron transport system, 
hemolysins, a putative superoxide dismutase, a bacterioferritin homologue, and iron 
dependent repressors  (Bates et al, 2005).  S. pyogenes produces iron acquisition proteins 
2 
(siderophores, hemophores, or specific receptors) to obtain more iron when the 
concentration is limited  (Bates et al, 2003).  The bacterium cannot extract iron from 
transferring or lactoferrin  (Eichenbaum et al., 1996a; Eichenbaum et al, 1996b). 
Heme or hemoglobin is an essential iron source in vivo  (Bates et al, 2003; Bates 
et al, 2005).  Studies in an iron-depleted medium experiment showed that heme in sheep 
blood aided S. pyogenes growth.  S. pyogenes can also extract heme from myoglobin, 
heme-albumin, haptoglobin-hemoglobin complexes, and hemopexin:hemoglobin 
complexes.  S. pyogenes utilizes surface receptors to bind hemoglobin and other 
hemoproteins  (Bates et al, 2003).   
 
SiaABC.  S. pyogenes use SiaABC to acquire heme (Figure 1)  (Bates et al, 2003; Bates 
et al, 2005; Liu et al, 2005).  SiaABC is the streptococcal iron acquisition ABC 
transporter  (Bates et al, 2003; Bates et al, 2005). Another name for SiaABC is HtsABC, 
the heme transporter of group A streptococcus  (Liu & Lei, 2005). The SiaABC 
(HtsABC) is made up of three genes in a ten gene cluster: spy1793, spy1794, and 
spy1795  (Bates et al, 2003; Lei et al., 2003). SiaA (HtsA, spy1795) is a lipoprotein 
located on the cell surface and serves as a heme binding protein. SiaB (HtsB, spy1794) is 
the membrane permease.  SiaC (HtsC, spy1793) is the ATPase that is uses the energy of 
ATP for heme import. 
 
SiaA.  SiaA binds both hemoglobin and heme  (Bates et al, 2003; Lei et al, 2003; Liu et 
al, 2005).  A recombinant form of SiaA (rSiaA) was constructed in which the lipoprotein 
tail of SiaA at the N-terminus was replaced with a His-tag Xpress epitope (Figure 2)  
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(Bates et al, 2003).  Western blot and SDS-PAGE showed that the recombinant protein 
bound hemoglobin.  Enterokinase (EK) cleavage and hemoglobin-binding assays showed 
that rSiaA both with and without His-Xpress epitope were able to bind hemoglobin.  
In the binding assay experiment, transferrin served as a control and did not bind 
hemoglobin  (Bates et al, 2003).  A solid phase binding assay showed that SiaA could 
form a stable complex with hemoglobin but it could not bind myoglobin or hemoglobin-
haptoglobin complexes.  However, it can acquire iron from these species, indicating that 
S. pyogenes needs additional proteins to take up heme and transport it to SiaA 
(Eichenbaum et al, 1996b). 
When SiaA was expressed and purified in E. coli, the sample shows an intense red 
color  (Bates et al, 2003; Lei et al, 2003; Liu et al, 2005).  This was due to the presence of 
heme in the heme-binding protein.  The UV-visible absorption spectrum for SiaA showed 
peaks at 275, 370, 417, 530, and 560 nm  (Lei et al, 2003).  The SDS-PAGE indicated 
that SiaA was about 35 kDa (Bates et al., 2003; Lei et al., 2003; Liu & Lei, 2005).  As 
isolated, recombinant SiaA contained about 0.25 bound heme molecule, whereas 
reconstituted SiaA contained about 1.0 bound heme molecules  (Liu et al, 2005). 
 
ABC Transporters.  ATP-binding cassette (ABC) proteins are multi-domain structures 
that use the energy of ATP hydrolysis to translocate solutes across cellular membranes 
(Figure 3)  (Jones & George, 2004; Jones & George, 2005).  ABC transporters are made 
up of two transmembrane domains (TMDs) and two nucleotide-binding domains (NBDs).  
The TMDs act as the substrate binding sites, while the NBDs, molecular motors, use ATP 
energy for conformational change to transport the solutes  (Jones et al, 2004).  The TMDs 
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contain multiple hydrophobic segments.  They consist of α-helices that form six to eleven 
membrane spanning regions and form the transmembrane channel.  These TMDs are 
substrate-specific.  They connect to an intra-cytoplasmic helix bundle, which interacts 
with the NBDs.  
The NBDs are located in the cytoplasm  (Jones et al, 2004).  They contain Walker 
A and B motifs and a highly conserved (C) motif known as the “LSGGQ” motif.   The 
Walker A and B motifs are consensus sequences for nucleotide binding.  They are 
separated by approximately 90 – 120 amino acids.  The Walker A motif (G-X-X-G-X-G-
K-S/T) is a phosphate binding (P) site consisting of a glycine loop followed by an 
uncapped α-helix.  Its function is to bind the nucleotide through electrostatic interactions 
with the triphosphate moiety.  The Walker B motif contains four hydrophobic residues 
and an aspartate.  The Walker B motif consists of a ß strand within the core of the 
nucleotide-binding fold.  To maintain the geometry of the active site, the Walker B 
aspartate hydrogen bonds to ligands coordinated to the catalytic Mg2+ ion.  The C motif is 
the signature sequence of ABC transporters.  It is located after the Walker B sequence. 
ABC transporters are found in both prokaryotes and eukaryotes  (Jones et al, 
2004).  They are mostly unidirectional.  Eukaryotes use ABC proteins as exporters while 
prokaryotes use them as importers.  In prokaryotes, the Gram-negative ABC protein is a 
periplasmic binding protein dependent transporter  (Higgins, 1992; Higgins & Linton, 
2001; Higgins, 2001).  The Gram-positive ABC protein is a binding lipoprotein 
dependent transporter.  The importers have four polypeptide subunits (two TMDs and 
two NBDs) and accessory periplasmic binding proteins (PBPs).  In general, each ABC 
transporter has a PBP fused to each TMD, meaning that there are two substrate transfer 
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sites at the PBP-TMD interfaces.  Eukaryotes exporter do not have PBPs.  The exporters 
are made up of a single polypeptide with the TMD connected to the C-terminal end of 
each NBD.  The ABC importers contain TMDs that range from 8 to 20 transmembrane 
helices  (Locher, 2004).  The ABC exporters TMDs have a total of 12 transmembrane 
helices. 
 The TMDs and NBDs are organized in the order NH3+-TMD-NBD-TMD-NBD-
COO- for a full transporter  (Higgins, 1992; Higgins, 2001; Higgins et al, 2001). 
Sometimes, half-transporters are present in both prokaryotes and eukaryotes.  Half-
transporters are comprised of one TMD and one NBD.  Each TMD is covalently fused to 
a C-terminal NBD.  Otherwise, each TMD is initially fused to an N-terminal NBD then 
followed by a TMD  (Jones et al, 2004).  Half-transporters can be homodimers or 
heterodimers. 
 
The cobalamin ABC transporter: BtuCDF.  Btu (B twelve uptake) is an E. coli protein 
assembly that imports vitamin B12  (Karpowich et al., 2003).  Btu includes the ABC 
transporter BtuCD, the periplasmic binding protein (PBP) BtuF, and the outer membrane 
transporter BtuB.  In the BtuCD, there are two copies of the membrane-spanning BtuC 
subunit  (Locher & Borths, 2004).  There are also two copies of the BtuD subunits which 
are the nucleotide binding domains.  The BtuC and BtuD subunits form a functional 
heterotetramer (BtuC2D2).  On the interface of the BtuC2 subunits, two pairs of helices in 
an anti-parallel arrangement form a single translocation pathway.  The pathway has a 
cavity that opens to the periplasmic space and allows the corrin ring of vitamin B12 to fit.  
After binding vitamin B12, the residues in two loops of the cavity are closed to the 
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cytoplasm.  On the cytoplasmic side, the BtuD subunits are aligned such that the 
nucleotide is bound at the dimer interface.  The ATP molecule binds against the P-loop of 
the opposite subunit.  Locher speculates that the membrane spanning BtuC subunits keep 
the BtuD subunits properly aligned through extensive interdomain interactions   (Locher 
et al, 2004).  After hydrolysis, the conformational changes from ATP binding are 
transmitted through various loops in the conserved NBD region to the BtuC subunit  
(Borths et al., 2002).  Locher has proposed that the amino acid residues of the BtuD 
subunits involved in the interface with BtuC are clustered around the Q-loop  (Locher et 
al, 2004). The Q-loop acts as a λ-phosphate sensor, which changes the conformation upon 
nucleotide binding and hydrolysis. 
 
BtuF.  BtuF binds vitamin B12 and releases it to BtuCD channel (Figure 4)  (Borths et al, 
2002; Locher et al, 2004). BtuF consists of two globular (α/ß) domains connected by a 
rigid α-helix, α-6  (Karpowich et al, 2003).  Between the two domains, a deep cleft is 
formed, which is the substrate binding site.  Each globular domain has a secondary 
structure that alternates between α-helixes and parallel β–sheets at the N-terminus.  
Domain I starts at the N-terminus, while domain II starts at the C-terminus. Both domains 
are α/ß sandwiches.  Domain I consists of five-stranded parallel ß-sheet with α-helix 
connected to each strand.  Its α-5 helix lies against the interdomain α-6 helix to form a 
partial helical bundle, which contacts the B12 at its dimethylbenzimidazole (DMB) and 
propionamide groups.  Domain II consists of a four stranded parallel ß-sheet with 
connecting α-helix. Instead of α-5 helix, the C-terminal helix (α-11) packs against the 
interdomain α-6 helix. 
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 The B12 binding site of BtuF is acidic while the protein itself is basic  (Karpowich 
et al, 2003).  About 60% of the B12 is inside the binding cleft, held in by 11 residues that 
make direct contacts with B12 in both of the crystal structure monomers.  Domain I 
contacts B12 50 times with six residues while domain II uses 5 residues to contact B12 39 
times.   
 
Iron acquisition in bacteria.  Many pathogenic bacteria use their iron acquisition 
mechanisms to live inside hosts.  Iron acquisition is necessary because free iron is an 
important nutrient factor for bacterial infection  (Skaar & Schneewind, 2004).  Although 
humans have an abundant amount of iron, essentially all of it is bound, largely by 
proteins.  An iron limited environment is a hostile environment for the growth of bacteria 
unless they have mechanisms to access these bound iron atoms.  In humans, 
hemoproteins (largely hemoglobin and myoglobin) contain the majority of iron atoms  
(Mazmanian et al., 2003).  Erythrocytes carry 60 – 75% of the body’s iron content in 
hemoglobin. When erythrocytes lyse, hemoglobin is degraded and heme is released.  Free 
heme is not tolerated by cells.  Hemopexin binds the free heme and transports it back to 
the liver.  
 
Staphylococcus aureus Isd System.  S. aureus has an iron regulated surface determinant 
(Isd) system which is capable of binding and transporting heme  (Skaar et al, 2004).  
There are two ways that S. aureus obtains both free heme and hemoproteins and uses 
them as iron sources. One of these is through siderophore-dependent mechanisms.   
These use an iron chelator that has a high affinity for iron to remove and transport iron 
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atoms from host proteins into the bacterial cell.  Another way is through Isd gene 
clusters, which are only transcribed when concentrations of iron atoms are low. 
 The Isd system of S. aureus consists of IsdA, IsdB, IsdC, IsdD, IsdE, IsdF, SrtB, 
IsdG, IsdH, and IsdI (Figure 5)  (Skaar et al, 2004; Skaar et al., 2004).  These 
transcriptional units are made up of cell-wall anchored surface proteins (IsdABCH), a 
membrane transporter (IsdDEF), a sortase (SrtB), and two cytoplasmic proteins (IsdGI).  
The IsdABCH, IsdDEF, and IsdGI are involved in binding heme, while sortase acts as an 
enzyme to covalently attach specific proteins, to the cell wall.   
 
Sortase-mediated cell wall anchoring pathway.  Sortases, membrane anchored 
transpeptidases, are enzymes that catalyze amide linkage formation between the cell wall 
peptidoglycan and the C-terminus of a protein  (Jonsson et al., 2003; Skaar et al, 2004).  
These enzymes are also used to cleave LPXTG motifs of the protein.  The LPXTG motif 
is made up of five amino acids: leucine, proline, X, threonine, and glycine, where X is 
any amino acid.  The LPXTG motif, a hydrophobic region, and a tail of charged residues, 
all located near the carboxyl terminal, are the three factors that are necessary for the 
covalent adhesion between proteins and cell wall peptidoglycan  (Paterson & Mitchell, 
2004).  They act as the cell wall sorting signal.   
There are two types of sortases, sortase A and sortase B.  Sortase A anchors the 
LPXTG motif (IsdA, IsdB, and IsdH) of the Isd system to the bacteria cell wall  (Jonsson 
et al, 2003).  Sortase A recognizes the LPXTG motif by detecting acidic residues and the 
hydrophobic region of these three proteins  (Skaar et al, 2004).  Most of the time, sortase 
A is active.  When sortase A is inactivated, a covalent linkage between bacteria cell wall 
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and the protein cannot be established.  Sortase A substrates are anchored to the 
pentaglycine crossbridge of the staphylococcal cell wall; the inability to covalently 
anchor the proteins to the cell wall affects bacterial virulence.   Sortase B (srtB) anchors 
isdCDEFsrtBisdG proteins, which are involved in binding heme, to the cell wall of the 
bacteria.  
The Isd proteins in sortase A and sortase B are under the regulation of the iron-
dependent repressor Fur, a ferric-uptake regulator protein  (Skaar et al, 2004; Jonsson et 
al, 2003).  Fur is a repressor gene that controls the production of Isd proteins  (Maresso & 
Schneewind, 2006).  Fur functions as a regulator that senses and responds to the need to 
acquire iron from the environment.  When bacteria sense the exhaustion of iron, Fur 
activates the production of Isd proteins.  Sortase B, IsdA, IsdB, IsdC, and IsdH can then 
be assembled to ensure successful nutrient acquisition.  
Inactivation of sortases reveals that the Isd system has a role in uptake of heme 
iron atoms into the bacteria  (Skaar et al, 2004).  With the inactivation of sortase A, the 
level of heme iron in S. aureus is decreased due to the reduction of heme being 
transported into the cell.  As the result, S. aureus does not have the ability to bind to 
hemoglobin as before and its virulence is diminished.  Sortase B does not reduce bacteria 
virulence greatly when it is inactivated.  However, it reduces the persistent infection of S. 
aureus in tissues.  This is thought to be due to an inability to acquire heme iron atoms 
from the host through the loss of IsdC anchoring.  
 
Perisplasmic binding protein.  Most PBPs contain two globular domains that are 
connected by a hinge region  (Eakanunkul et al., 2005).  The pocket between the two 
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domains forms the binding site.  The PBP consists of three groups.  Group I has three 
interdomain connections, group II has two interdomain connections, and group III has 
one interdomain connection (α-helical).  The proteins BtuF and FhuD are part of group 
III PBPs and sequence homology suggests that ShuT is also a Group III PBP.   
 
ShuT.  ShuT, a PBP, binds heme in Shigella dysenteriae  (Eakanunkul et al, 2005).  It 
transports heme to the proteins ShuUV, which are a cytoplasmic permease and an 
ATPase. The sequence of ShuT is similar to the sequences of BtuF and FhuD.  
ShuT is a monomeric protein  (Eakanunkul et al, 2005). SDS-PAGE and size 
exclusion chromatography show that ShuT has a molecular weight of approximately 28.5 
kDa.  ShuT binds one b-type heme per monomer.  Tyr94 is the only axial ligand.  Tyr228 
helps to stabilize the interaction between the ligand and ShuT; it does not directly interact 
with heme iron.  
 
FhuD.  FhuD, a PBP, binds hydroxamate-type siderophores in E. coli  (Clarke et al., 
2002b; Clarke et al., 2002a; Krewulak et al., 2005; Carter et al., 2006). It obtains 
siderophores from FhuA, an outer membrane receptor, and transports them to FhuBC, the 
inner membrane ATP-binding cassette transporter.  FhuD has a molecular mass of 32 
kDa.  It has two distinct domains that are connected by a long α-helical backbone.  The 
N-terminal domain consists of five β-sheets and four α-helices while the C-terminal 
domain has two β-sheets with three α-helices.  The shallow pocket between the two 
domains makes up the siderophore binding site.  The pocket is hydrophobic and has 
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aromatic residues. The movement of amino acid side chains in the binding cleft allows a 
variety of hydroxamate-type siderophores to bind. 
Siderophores bind to FhuD through both hydrophobic and hydrophilic 
interactions  (Clarke et al, 2002b; Clarke et al, 2002a; Carter et al, 2006). When the 
siderophore binds, its methylene carbon atoms form hydrophobic interactions with 
aromatic FhuD residues.  There are three hydrogen bonds formed between albomycin and 
FhuD. Two of the hydrogen bonds form between the hydroxamate and the FhuD residue 
Arg84 while the other forms between the hydroxamate and Tyr106. Similar to the 
albomycin binding, the interactions between gallichrome and FhuD also show hydrogen 
bonding, except that there is an intermediate water molecule. 
 
MntC.  In C. synechocytis, MntC is the periplasmic binding protein for the manganese 
(Mn2+) ABC transport system  (Rukhman et al., 2005).  MntC has two globular domains 
connected by an α-helix.  His89, His154, Glu220, and Asp295 are proposed to be the 
ligands to the manganese.  The metal ion-binding site is asymmetric in that the two 
negatively-charged residues are located closer to the manganese ion than the two 
histidine residues.   
 The crystal structure of MntC shows three monomers (A, B, and C) in the unit 
cell  (Rukhman et al, 2005).  Each monomer has four domains: the N-terminal upper 
globular domain, the α-helical backbone, the lower globular domain, and the C-terminal 
domain.   
 MntC has a disulfide bond between Cys219 and Cys268 close to the surface  
(Rukhman et al, 2005).  Cys219 is located before Glu220, which binds Mn2+.  The loop 
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that contains Cys268 is in contact with the loop that contains Asp295, which also binds 
Mn2+.  Reduction of the disulfide bond lowers the affinity of MntC toward Mn2+.    
 Monomer C is more disordered that either A or B  (Rukhman et al, 2005).  Most 
of the disordered region is localized in the lower domain.  The disulfide bond in this 
monomer has weaker electron density, which may indicate that the cysteine side chains 
adopt a number of conformations.  The poor electron density on Glu220 shows that this 
residue is flexible.  The electron density at the Mn2+ of monomer C is weaker than the 
density at the Mn2+ of monomers A and B, indicating there is a lower metal ion 
occupancy in this monomer.  The Mn2+ binding site is also 0.5 Å further from Glu220 
and closer to His89.  Rukhman et al. propose that the disulfide bond in monomer C is 
heterogeneous, with partial reduction leading to movements in the lower domain  
(Rukhman et al, 2005).  
 
HasA.  HasA is an extracellular heme binding protein.  It is secreted by bacteria; its 
function is to bind heme and transport it to an outer membrane receptor.   Most studies 
have been performed on the protein from Serratia marcescens  (Deniau et al., 2003; 
Deniau et al., 2001).  The crystal structure shows that the holoprotein is made up of four 
α-helices and six β-sheets  (Arnoux et al., 1999).  The four α-helices are on the same side 
of the protein.  The two loops at the interface between the α-helices and the β-strands 
hold the heme.   The heme propionates point toward the solvent.  With hydrophobic 
binding pocket residues, heme binding maintains its stability through the help of polar 
interactions. These include three hydrogen bonds that interact with propionate groups, 
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two axial bonds, and a network of hydrogen bonds between the core of the protein and 
residues of the binding pocket. 
The axial ligands are histidine (H32) and tyrosine (Y75).  Through hydrogen 
bonding, asparagine (N41) and histidine (H83) residues are linked to the axial ligands.  
Asparagine, glycine, and tyrosine (N34, G35, and Y137) residues are linked to heme 
propionate groups.  
The tyrosine (Y75) is bound to the heme iron with the bond length of 2.0 Å while 
histidine (H32) is bound to the heme with the bond length of 2.32 Å.  Studies of mutation 
of Y75 (Y75A) suggests that H83 can replace Y75 in binding heme  (Arnoux et al, 1999).  
Although H83 does not directly bind the iron, evidence from thermodynamics 
experiments show that H83 is the main factor in affecting the heme binding.  When 
alanine (H83A) or glutamine (H83Q) replaces histidine, the affinity of the heme binding 
is reduced by 260 and 150 times, respectively.  Comparing to the mutation of histidine 
axial ligand (H32A), the mutation of H83 induces a higher loss of affinity.  The 
interaction of H83 with Y75 indicates that the hydrogen bonding enhances the 
nucleophilic of Y75.  It helps holding the tyrosine ring in the correct orientation so that 
Y75 can bind to iron.   
 
Campylobacter jejuni.  Campylobacter jejuni is a rod-shaped, curved pathogenic 
bacterium that causes food borne infection, especially diarrhea  (Muller et al., 2006).  C. 
jejuni is a gram negative bacterium and is commonly found in animal feces.  C. jejuni 
needs iron (Fe) to survive. 
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C. jejuni uses the enterobactin siderophore to take up iron  (Muller et al, 2006).  
Enterobactin is an iron chelator and consists of triscatechol (metal binding units) that are 
linked via amides to a triserine ring (the backbone).  Enterobactin chelates iron through 
triscatechol ligands, forming a Δ configuration.   
CeuE is a ferric enterobactin binding protein of C. jejuni  (Muller et al, 2006).  
CeuE is made up of α-helices and β-strands; the majority of the protein consists of α-
helices.  Two α-helices span the protein, while six β-strands are located at one end of the 
protein and seven are located at the other.   
Enterobactin binds iron, forming a ferric-enterobactin complex (FeEnt)  
(Raymond & Dertz, 2004)  (Raymond et al., 2003; Raymond et al, 2004).  A cell surface 
receptor protein recognizes the FeEnt and transports it into the periplasm.  Subsequently, 
the periplasmic binding protein, CeuE, binds the FeEnt and transfers it to a membrane-
bound protein that transports it to the cytoplasm.  
H6-mecam is one of the synthetic tris-catecholamide ligands that mimic 
enterobactin  (Muller et al, 2006).  CeuE recognizes H6-mecam through a combination of 
the α-helices, β-strands, and loops.  There is no direct binding between iron and the 
protein.  The residues closest to the H6-mecam are Arg249, Tyr288, Arg205, Arg118, and 
Lys121.  
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Materials and Methods: 
 
Homologous structure: 3D-JIGSAW.  The sequence of wild type SiaA was submitted 
to the 3D-JIGSAW website (http://www.bmm.icnet.uk/servers/3djigsaw/).  The 
homologous structures for BtuF (1N4D) were selected.  The graphical coordinates of the 
homology models (starting with the line ATOM 1) were saved as a txt file.  The file was 
renamed as a pdb file and opened with Rasmol 2.7.2.2.2.1 (originally developed by Roger 
Sayle). 
 
Homologous structure: LOOPP.  The sequence of wild type SiaA was submitted to the 
LOOPP website (http://cbsuapps.tc.cornell.edu/loopp.aspx).  The homologous structures 
for BtuF (1N4A), CeuE (2CHU), and FhuD (1K7S) were selected.  The graphical 
coordinates of the homology models (starting with the line ATOM 1) were saved as pdb 
files and opened with Rasmol. 
 
General.  UV-vis spectra were taken on a 50-Bio (Varian, Palo Alto, CA) UV-visible 
spectrophotometer.  Water (18.2 MΩ) was from a NANOpure DiamondTM water purifier 
(Barnstead International, Dubuque, IA).  The H229A mutant was a gift of Dr. Zehava 
Eichenbaum (2aH XUB LB-AMP), stored in a cryovial at -80 °C. 
 
Preparation of Luria-Bertani media.  Luria-Bertani (LB) media (2 L) was prepared 
with 20 g BactoTM Tryptone (Becton Dickinson, Sparks, MD), 20 g NaCl, and 10 g 
Bacto® Yeast Extract (Becton Dickinson) in 1940 mL water.  The solution was adjusted 
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to pH 7.0.  The broth was autoclaved on a liquid cycle for 45 min and allowed to cool.  
Ampicillin (amp) stock solution (100 mg/mL) was made by dissolving 1000 mg 
ampicillin sodium salt (Fisher, Fairlawn, NJ) in 10 mL of sterile water. Ampicillin stock 
solution (2 mL) was added to the 2 L sterile broth. The resultant solution (2 L LB + 2 mL 
amp broth) was stored at 4 °C.   
 A second complete protocol was performed as above except that 3 L of broth was 
made with 30 g BactoTM Tryptone (Becton Dickinson, Sparks, MD), 30 g NaCl, and 15 g 
Bacto® Yeast Extract (Becton Dickinson) in 2910 mL water with 3 mL amp broth. 
  
Inoculation of LB media and the growth of H229A.  From the 2 L of LB + 2 mL amp 
broth, 100 mL were transferred to each of the two 125 mL Erlenmeyer flasks.  A loop of 
mutant H229A was transferred into each flask.  The broth was stirred with the same 
inoculating loop. The cryovial containing H229A was immediately put back into the -80 
°C freezer.  Both flasks were covered with slightly loosened aluminum foil that allowed 
air to circulate and were incubated for 16 h at 37 °C with shaking at 200 rpm.  The broth 
had an OD660 of approximately 1.  The remaining LB media was divided into two 3000 
mL Erlenmeyer flasks (~900 mL each). To each flask, 100 mL inoculated broth with 
H229A was added.  Two 3000 mL flasks were again placed in the shaker for 3 h at 37 °C 
with 200 rpm.  
 A 2.0% arabinose stock solution was prepared by diluting 4 g of L-arabinose 
(Acros Organics, Morris Plains, NJ) in 200 mL of water.  The solution was vortexed to 
dissolve the solid and filtered through a 0.20 µm MF75 Nalgene filter unit (Nalgene 
Labware, Rochester, NY).  
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After 3 h of shaking, arabinose stock solution (0.05 mL) was added to each flask.  The 
flasks continued to inoculate at 37 °C with shaking at 200 rpm for 4 h. 
 Similar to the first run, a second complete protocol was performed as above 
except that 100 mL were transferred to each of the three 125 mL Erlenmeyer flasks.  
After 16 h of incubation, the growth media was cloudy and had an OD660 of 
approximately 2.8 (using LB broth as a baseline).  The remaining LB media was divided 
into three 2800 mL Erlenmeyer flasks (~900 mL each).  To each flask, 125 mL 
inoculated broth with H229A was added.  Three 2800 mL flasks were again placed in the 
shaker for 3 h at 37 °C with 200 rpm.  After 3 h of shaking, the growth media had an 
OD660 of approximately 2.5.  The arabinose stock solution (5.0 mL) was added to each 
flask.  The flasks continued to inoculate at 37 °C with shaking at 200 rpm for 4 h.  The 
growth media had an OD660 of approximately 5. 
 
Centrifugation.  The inoculated sample was transferred to eight sterile plastic centrifuge 
bottles and centrifuged at 8000 x g for 10 min at 4 °C (Eppendorf Centrifuge 5804 R).  
The supernatant was discarded.  The collecting pellets were placed in cryogenic vials and 
stored in the freezer at  
-20 °C. 
 
French press procedure.  Extraction buffer was prepared by dissolving 2.42 g of 20 mM 
Tris (Fisher Chemicals, Fair Lawn, NJ), 5.84 g of 100 mM NaCl (Aldrich Chemical 
Company, Milwaukee, WI), and 1 mL of neat 0.1% Triton (MP Biomedicals) in 1 L 
water to give a buffer solution of 50 mM Tris.  The extraction buffer was adjusted to pH 
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8.0 using HCl.  To each of three falcon tubes, two Complete Mini EDTA-free protease 
inhibitor tablets (Roche Diagnostics, Indianapolis, IN) were dissolved in 30 mL of 
extraction buffer.  Each tube was vortexed until the tablet was dissolved.  The solutions 
were allowed to stand until the bubbles had dissipated.  Approximately 9 g of cell pellets 
were diluted 1:10 by mixing with extraction buffer at 4 °C.  This solution was divided 
equally onto the three falcon tubes and mixed with extraction buffer by vortexing. The 
falcon tubes were placed on ice.  Using a SIM-AMINCO Spectronic Instruments French 
R Pressure Cell Press, each faction was French pressed at a setting of 1200-1280 on the 
high ratio unit.  Each drop was collected in a falcon tube on ice. Each sample was French 
pressed twice.  The samples were centrifuged at 12000 x g for 10 min. The 90 mL of 
supernatants were collected and the pellets were discarded.  Supernatants were 
concentrated to 35 mL using 15 mL cellulose 5,000 MWCO tube in an Amicon Ultra 
centrifugal filter device (Millipore, Billerica, MA). 
A second complete protocol was carried out as above except that 100 mL of 
glycerol (Fisher Scientific, Fair Lawn, NJ) was added into the extraction buffer to make 
50 mM Tris plus 10% glycerol.  To each of two falcon tubes, two Complete Mini EDTA-
free protease inhibitor tablets (Roche Diagnostics, Indianapolis, IN) were dissolved in 45 
mL of extraction buffer.  Each tube was vortexed until the tablets were dissolved.  The 
solutions were allowed to stand until the bubbles had dissipated.  Approximately 5 mL of 
cell pellets were added into each of the falcon tube and mixed by vortexing.  The falcon 
tubes then placed on ice.  Using a SIM-AMINCO Spectronic Instruments French R 
Pressure Cell Press, each faction was French pressed at a setting of 1200-1280 on the 
high ratio unit.  The output was collected in two falcon tubes on ice.  These samples were 
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treated again with the French press and the output collected as second time.  The samples 
were centrifuged at 20,000 x g for 25 min.  The supernatants (~100 mL) were collected 
and syringe filtered using a sterile Millex-HV Syringe Driven filter unit with 0.45 μm 
PVDF filter (Millipore, Bedford, MA) into three falcon tubes.  One of these tubes was 
used for nickel affinity purification (below) and the other two were stored at -80 oC.  The 
pellets were discarded.  
 
Nickel affinity fast protein liquid chromatography (FPLC) preparation.  Extraction 
buffer (1 L) was prepared as described above.  Binding buffer (buffer A) was prepared as 
follows.  K2HPO4 (87.09 g) was dissolved in a 500 mL volumetric flask of water.  
KH2PO4 (68.05 g) was dissolved in a second 500 mL volumetric flask of water.  The first 
solution (80.2 mL) and the second solution (19.8 mL) were placed in a 2 L Pyrex bottle.  
To this was added 29.22 g of NaCl and water added to make a 2 L solution.  The pH was 
adjusted to 7.4; and the solution was filtered by using a 0.45 µM pore size in a Nalgene 
vacuum filter unit (Nalgene, Rochester, NY).  The final solution was 50 mM potassium 
phosphate with 250 mM NaCl at pH 7.4.   
 Buffer B (elution buffer) was prepared by diluting 68.08 g of 0.5 M imidazole in 
1 L of Buffer A.  The final solution (2 L) was vacuum filtered before use.  Stripping 
buffer (1 L) was prepared by adding 18.61 g of 0.05 M 2 Na-EDTA to 1 L of Buffer A.  
The pH was made to 7.4, the solution was vacuum filtered before use.  A 100 mL nickel 
charging solution was prepared by adding 2.38 g of 0.1 M NiCl2 (Mallinckrodt Chemical 
Works, St. Louis, MO) to a 100 mL volumetric flask and diluting with water to 100 mL.  
The solution was vacuum filtered before use. 
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 A HiTrap® Chelating HP nickel column (GE Healthcare Bio-sciences) was 
washed with 5-10 column volumes (1 CV = 5 mL) of water prior to charging to remove 
any contaminants present.  The column was washed with 5-10 CV of stripping buffer, 
then at least 5-10 CV of binding buffer, and then 5-10 CV of water at 4.0 mL per min 
with a pressure under 0.3 MPa.  The column was charged with 4 CV of nickel charging 
solution at 0.5 mL per min.  The column was then washed with 5 CV of water and 5 CV 
of binding buffer at 4.0 mL per min.  Pump A, pump B, and the 5 mL column were 
washed with water.  The column was equilibrated with 5 CV binding buffer at 4.0 mL per 
min.  The 50 mL super loop was washed with water.  The H229A sample was injected 
into the super loop.  Line A was placed into the binding buffer and line B was placed into 
the elution buffer.  The flow rate of the injection gradient elution was set at 0.2 mL per 
min with the column pressure limit of 0.3 MPa.  The fractions were collected in 
disposable glass culture tubes.  Fractions 1-9 and 15-30 were kept and the rest discarded.  
After the run, the pumps were washed with water and then with 20% aqueous ethanol for 
storage. 
 A second complete protocol was performed as above except that Buffer A and 
Buffer B had 10% glycerol in each (a gift of Brian Sook, Georgia State University).  For 
this run, fractions 16-33 were kept and the rest discarded.   
 The sample from collected fractions was taken for UV-vis spectrum through using 
cord cell.  Buffer A was used for the baseline. 
 
Gel electrophoresis.  A 1.5 M Tris pH 8.8 buffer was made by dissolving 36.34 g Tris 
(FisherBiotech, Fair Lawn, NJ) in water to make a 200 mL stock solution.  The pH was 
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adjusted to 8.8 using HCl.  A 1.0 M Tris pH 6.8 buffer was prepared by diluting 11.11 g 
Tris in water to make a 100 mL stock solution.  The pH was adjusted to 6.8 using HCl. 
The 10% sodium dodecyl sulfate (SDS) was made by mixing 1 g SDS (Fisher, Fair 
Lawn, NJ) in 10 mL water.  The 10% APS, ammonium persulfate, was prepared by 
suspending 1 g ampicillin sodium salt (FisherBiotech, Fair Lawn, NJ) in 10 mL of water.  
Two plates of 1.0 mm gels were made by preparing 15% resolving layer (bottom layer) 
and 5% stacking layer (top layer).  Resolving layer was prepared by dissolving 2.3 mL 
water, 5.0 mL of 30% bisacrylamide (FisherBiotech, Fair Lawn, NJ), 2.5 mL of 1.5 M 
Tris pH 8.8, 100 µL of 10% SDS, and100 µL of 10% APS.  Immediately before putting 
the gels solution into the gels maker, 4 µL TEMED (N,N,N’,N’-tetra-methyl-
ethylenediamine, Bio-Rad Laboratories, Hercules, GA) was added onto the solution and 
inverted five times to mix.  The gel solution was filled up to 2/3 of the plate.  A 1 mL of 
2-propanol (Fischer Chemicals, Fair Lawn, NJ) was added onto the gels maker.  While 
waiting for the resolving layer to solidify, a stacking layer was prepared by dissolving 6.8 
mL water, 1.7 mL of 30% bisacrylamide, 1.25 mL of 1.0 M Tris pH 6.8, 100 µL of 10% 
SDS, and 100 µL of 10% APS.  When the resolving layer had solidified, water was used 
to remove the 2-propanol.  Filter paper was used to remove the water.  TEMED (10 µL) 
was added to the stacking solution and inverted five times to mix.  The solution was then 
added onto the top of the resolving layer.  The 1.0 mm comb was added to the gel maker 
to make lanes.  After the gels had solidified, both gels were washed with water under 
light pressure, wrapped with moisture paper towels, and kept in the refrigerator at 4 °C. 
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SDS-PAGE of nickel affinity FPLC fractions.  The gels were loaded into a Mini 
PROTEAN® 3 Cell (Bio-Rad).  A 500 mL running buffer at pH 8.3 was prepared by 
diluting 50 mL of 10 X Tris-glycine-SDS buffer (Fisher cat. BP1341-1) with 450 mL 
water.  The running buffer was poured into the Mini PROTEAN® 3 Cell.  Mixed 
Laemmli sample buffer was made by adding 50 μL 2-mercaptoethanol (Bio-Rad) with 
450 μL of Laemmli sample buffer (Bio-Rad).  A 5 μL sample was taken from each of the 
affinity FPLC fractions 4, 6, 16, 17, 18, 21, 23, 25, 27, and 28.  Each of these was mixed 
with 10 μL of mixed Laemmli sample buffer.  Samples were centrifuged for 15 sec on a 
VWR mini-centrifuge C-1200 and heated for 5 min at 103°C.  Five μL of Precision Plus 
Protein® molecular weight marker standard (Bio-Rad) were added to lane one.  Heated 
samples were loaded into the remaining gel lanes.  The gel was run at 60 – 80 V until the 
blue Laemmli sample buffer band was 1 cm below the lanes, at which point the voltage 
was increased to 100 – 120 V until the dye reached the bottom of the gel.  
 Destaining solution was made by combing 5 parts methanol (Fisher) to 1 part 
glacial acetic acid (EMD Chemicals, Gibbstown, NJ) and 4 parts water.  A Coomassie® 
Blue staining solution was prepared by dissolving 0.25 g of Coomassie® Brilliant Blue 
R-250 (Bio-Rad, Hercules, CA) into 100 mL of destaining solution.  The gels were 
removed and stained in the staining solution for 30 min and destained for 2 h on a rotary 
shaker.  The gels were washed with deionized water three times for two min each.  The 
water was emptied and Gel-DryTM Drying solution (Invitrogen, Carlsbad, CA) was added.  
The gel was equilibrated by shaking the gel for 20 min in the StainEaseR Gel Staining 
Tray.  The gel was removed and placed between two celloplane sheets. 
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A second complete protocol was performed as above except that mixed Laemmli 
sample buffer was made by adding 25 μL 2-mercaptoethanol (Bio-Rad) with 475 μL of 
Laemmli sample buffer (Bio-Rad).  A 5 μL sample was taken from each of the affinity 
FPLC fractions 18, 19, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, and 35.   
 The gels were removed and stained in the staining solution for 45 min and 
destained overnight (approximately 12 h) on a rotary shaker.   
 
Exchanging imidazole buffer into 10 mM Tris pH 8 to remove salt for anion 
exchange FPLC.  A solution of 10 mM Tris pH 8.0 was prepared by dissolving 10 mL of 
1 M Tris Buffer pH 8 stock solution (FisherBiotech, Fair Lawn, NJ) in 990 mL of water 
and the pH adjusted to 8.0.  The solution was filtered using a 0.45 µM pore size 
surfactant free cellulose acetate membrane in a Nalgene vacuum filter unit (Nalgene, 
Rochester, NY).  Fractions 25 through 31 from the first run of the nickel affinity FPLC 
were combined and placed into three Amicon Ultra 15 filter units with a 5,000 MWCO 
Ultracel membrane (Millipore, Billerica, MA). The tubes were centrifuged at 5000 x g for 
15 min at 4°C.  Approximately 5 ml of 10 mM Tris was added to the remaining protein 
solution in each tube and the tubes were centrifuged in the same manner again.  This 
process was repeated 4 times and yielded a total of 4.5 mL of a solution of protein in 10 
mM Tris pH 8. 
 
Anion exchange FPLC.  Starting buffer was prepared by adding 10 mL 1 M Tris 
(Fisher, Fair Lawn, NJ) to 990 mL of water.  The solution was filtered as described above 
and adjusted to pH 8.0 by adding HCl.  Elution buffer was made by mixing 500 mL of 
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start buffer with 500 mL of 1 M NaCl (which was prepared by diluting 29.22 g of NaCl 
in 500 mL of water). The solution was filter and adjusted to pH 8.0 as described above. 
 The FPLC was fitted with a HiTrapTM Q HP 5 mL (GE Healthcare Bio-sciences) 
column and washed with water.  Pumps A and B were also washed with water.  The 
column was washed with ten CV of anion exchange start buffer (10 mM Tris-HCl pH 
8.0), five CV of anion exchange elution buffer (anion exchange start buffer and 1.0 M 
NaCl), and then equilibrated with seven CV of anion exchange start buffer.  The 4.5 mL 
protein solution was loaded into the superloop and injected into the column.  Elution of 
the protein was performed by running five CV of anion exchange start buffer through the 
column followed with a 10 CV linear gradient.  The gradient began with 100% anion 
exchange start buffer and ended with 100% anion exchange elution buffer.  Fractions 6 to 
11 were collected. 
 
Exchanging imidazole buffer to water for mass spectrometry.  From second run, 
fraction 32 (25 μL) was placed in a Microcon Utracel YM-3 filter unit with 3,000 
MWCO (Millipore, Bedford, MA).  The sample was centrifuged at 3000 x g for 45 min at 
4°C.  The sample was centrifuged for additional 20 min until the sample was reduced to 
10 μL. Water (20 μL) was added onto the sample which was centrifuged for 45 min.  The 
process was repeated ten times.  ESI and MALDI mass spectra were taken; the sample 
still contained too much salt. 
 A second protocol was performed as above except that the sample (20 μL) was 
centrifuged at 1400 x g for 45 min.  This process repeated twice until the sample dropped 
to 7 μL.  Water (30 μL) was added and centrifuged two times for 60 min each.  Another 
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20 μL water was added and centrifuged 60 min.  This step was repeated a second time. 
ESI and MALDI mass spectra were taken.  The former was not successful; data for the 
latter are shown. 
 
SiaA thermal stability: Initial practice on myoglobin.  Phosphate buffer (50 mL) was 
prepared by mixing 2.5 mL of KH2PO4 with 3.97 mL of K2HPO4 in a falcon tube, and 
making the solution up to 50 mL.  A sample of myoglobin (100.0 µL solution of 
myoglobin in 10 mM Tris pH 8.0 was diluted in 1.00 mL of phosphate buffer)  from 
equine skeletal muscle (Sigma, St. Louis, MO) was placed in the UV cuvette, and 
absorbance reading at room temperature was taken.  The temperature was then raised to 
30 ºC and the absorbance was recorded.  After one hour, the absorbance was recorded 
again.  The UV spectrum was retaken after another h.  The temperature was increased by 
another 10 ºC and a spectrum was taken.  The absorbance was recorded again after one 
and two h.  This process was continued in temperature increments of 10 ºC until the 
temperature reached 70 ºC.  The myoglobin cuvette then sat at room temperature 
overnight.  The absorbance was recorded.  The temperature was then raised directly to 70 
ºC.  Uv-vis spectra were taken after about five minutes and again after 1 h.   
  
SiaA thermal denaturation: Initial practice on myoglobin.  Myoglobin was dissolved 
in the 50 mM pH 7.5 M buffer (discussed above under the nickel affinity column) to give 
an OD409 of approximately 0.1 and the pH adjusted down to 7.1 by adding dilute HCl.  
The height of the sample inside the cuvette was measured.  
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Using the ADL shell of the Varian-Cary, the temperature was programmed to 
start at 25 °C and end at 95 °C.  A 5 min equilibration time was added at the start of the 
run.  The temperature was increased at 0.5 °C per min with a signal averaging time of 0.5 
sec.  The wavelength was 409 nm.  When temperature reached 95 °C, the sample was 
removed and a blank buffer solution was re-measured.  The sample was allowed to cool 
down to room temperature.  The absorbance was re-recorded from 250 to 700 nm. The 
sample pH and its height were re-measured.   
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Results and Discussion: 
 
Homologous structure.  The sequence of wild type SiaA (Figure 6) was submitted to 
3D-JIGSAW, which searches the Protein Database (PDB) for homologous proteins.   
BtuF (1N4D) was returned by the program at the most homologous structure (Figure 7).  
The hypothetical 3D structure of wild type SiaA was created and allowed us to see the 
possible heme ligands included Met79, Tyr63, Tyr179, and His229. The LOOPP program 
gave three homologous structures, BtuF, CeuE, and FhuD (Figures 8, 9, and 10).  In all 
three cases, Met79 and His229 were in position to be possible axial ligands.  The 
structure of CeuE threaded into SiaA showed that Met79 and His229 were close to one 
another, and in excellent positions to bind heme.   
 Although the results of both JIGSAW and LOOPP did not included IsdE as a 
homologous structure, position specific iterative Blast (PSI-Blast) and pattern hit initiated 
Blast (PHI-Blast) both yielded IsdE at the most homologous structure to SiaA (Figure 
11).  SiaA and IsdeE sequences had 45% identical amino acids, 68% positives, and 0% 
gaps.  PSI-Blast and PHI-Blast showed that BtuF, FhuD, and CeuE had 20%, 25%, and 
22% identities, and 45%, 43%, 42% positives, and 2%, 11%, 8%  gaps, respectively, with 
the SiaA sequence. 
Homology modeling indicates that SiaA is made up mostly of α-helices.  From 
the homology modeling (Figure 7), it can be seen that Tyr179, Tyr63, His229, and Met79 
are all possible ligands.  We have proposed that SiaA binds heme through the axial 
ligands His229 and Met79.  It is also possible that histidine alone binds the heme.  The 
related Gram negative ShuT protein uses one tyrosine as an axial ligand, and has 
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significant interaction with the second  (Eakanunkul et al, 2005) so these are also 
possibilities.  Three additional axial ligand possibilities are Met/ Met, His/Tyr, and 
Tyr/Tyr.  However, few proteins containing Met/Met and His/Tyr axial ligands are 
known, and there are no known proteins containing Tyr/Tyr (Dixon, unpublished).  
Although His/His is a common ligand set, the two histidines are on the same side of the 
heme in the homology modeling, and are thus not in position to both be axial ligands 
simultaneously 
 
Growth and isolation of H229A SiaA.  Two fermentation runs (2 L and 3 L) of H229A 
SiaA plasmid in E. coli were performed. The 2 L fermentation run gave approximately 9 
g of cell pellets after centrifugation.  The cell pellets were lysed using a French press.  A 
sample of 90 mL was collected and concentrated to 35 mL for purification by nickel 
affinity FPLC.  
 Figure 12 shows the nickel affinity chromatogram.  Fractions 1 to 9 are run 
through. Fractions 15 to 24 show three peaks.  Fractions 25 to 31 show one peak.  
 The UV spectra were taken for fractions 4, 6, 16, 17, 18, 21, 23, 25, 27, and 28 
(Figure 13).  Fractions 4 and 6 showed very strong bands at 280, indicating substantial 
concentrations of protein in the flow through.  No heme bands were seen as shown by the 
absence of spectral intensity in the Soret region.  The spectra of fractions 16, 17, 18, 21, 
23 had shoulders at 420 nm, indicating the presence of heme proteins.  The spectra of 
fractions 25, 27, and 28 had peaks at 420 nm, indicating higher concentrations of 
holoprotein.   
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 SDS-PAGE (not shown) of fractions 4, 6, 16, 17, 18, 21, 23, 25, 27, and 28 was 
carried out. Fractions 4 and 6 showed clusters of bands.   Fractions 16, 17, 18, 21, and 23 
show many separated bands.  Fractions 25, 27, and 29 show one strong band, with a 
molecular weight appropriate for SiaA (Figure 14). Fractions 25 to 31 were combined 
and exchanged into 10 mM Tris buffer, pH 8.0 to give a final sample of 4.5 mL. 
 Anion exchange purification was performed on this sample (Figures 15 and 16).  
A series of 27 fractions were taken, with increasing concentrations of NaCl starting at 
fraction 15.  Three small peaks were seen.  The computer reset itself after peak 27.  
Figure 15 shows the subsequent fractions (labeling old fraction 28 as new fraction 1).  
Again, three components were seen, eluting at 0.70 to 0.83 M NaCl.  Samples were 
colorless. 
 SDS-PAGE (not shown) of fractions 21, 22, 23, and 25 of the first chromatogram 
and 7, 9, 10, and 11 of the second chromatogram was performed. No bands were seen.  
All fractions were lost.    
 In the 3 L fermentation run, approximately 10 mL of cell pellets were collected 
after centrifugation.  The cell pellets were lysed using a French press and the eluate was 
constantly kept on ice to prevent cleavage.  A sample of 90 mL was collected; 45 mL was 
used for purification by nickel affinity FPLC.  
 Figure 17 shows the nickel affinity chromatogram.  Fractions 16 to 36 were 
collected.   Fractions 17 to 22 and 28 to 33 were colorless while fractions 23 – 27 were a 
cloudy yellowish color.  Fractions 16 to 27 showed one major peak while fraction 28 to 
33 showed a smaller peak. 
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 The UV spectra were taken for fractions 17 to 22 (Figure 18) and 27 to 33 (Figure 
19).   All fractions showed bands at 280 and 420, indicating the presence of some apo- 
and some holoprotein.  The peak at 280 nm was larger than that at 420 nm indicating that 
these were a mixture of apo- and holoprotein [pure holoprotein has a 420/280 ratio of 
approximately 1.67 (Sook, unpublished)].  Figure 18 shows that the 420/280 nm ratio of 
all the fractions was approximately 0.2-0.3, indicating that apo- and holoproteins were 
not separating on the column. 
 A SDS-PAGE of the French pressed sample before chromatography and fractions 
18, 19, 22 to 26, and 27 to 35 of the nickel affinity column was carried out (Figure 20 and 
21).  The French pressed sample showed a cluster of bands, indicating the presence of 
multiple proteins.  Fractions 18, 19, 22, and 24 also showed clusters of bands.  Fractions 
23 to 28 showed many separated lighter bands.  Fractions 29 and 30 showed two bands 
with that at the approximate molecular weight of the SiaA far darker than the low 
molecular weight band.  Fractions 31 to 32 showed one strong band while fractions 33 to 
35 showed one lighter band.  
 From the SDS-PAGE, fractions 32 and 33 of the nickel affinity purification 
appeared to be pure (Figure 22).  Fraction 32 and 33 were selected for mass spectrometry. 
The material was stored in the -80 oC freezer. 
 
Mass spectrometry.  Initial MALDI and ESI mass spectra of fraction 32 had a mass of 
35441 Da.  However, the spectrum had a number of peaks and was very noisy, indicating 
substantial salt in the sample (Figures 23 and 24).  The expected mass of the protein is 
35421 Da (Figures 25, 26, and 27).  Thus, the experimental peak was within 20 Da of the 
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theoretical expectation (0.056%).  For MALDI, it is expected that the mass error will be 
less than 0.05% (18 Da in this instance).  For ESI it is expected that the mass error will be 
less than 0.02% (7 Da in this instance).  After desalting, the MALDI mass spectrum 
showed two peaks with molecular weights of 35386.6 Da and 35589.6 Da (Figures 28 
and 29).  Thus, one peak was too light by 34 Da and the other peak was too heavy by 169 
Da.  It was not known why desalting gave two peaks with masses that did not match the 
theoretical mass. 
A MALDI mass spectrum for fraction 33 was taken using carbonic anhydrase as 
an internal standard (Figure 30).  The sample had a mass of 35441 Da before desalting 
and 35527 Da after desalting (Figure 31).  Again, the peak appeared at higher mass after 
desalting.   
Before desalting, both fractions 32 and 33 had a mass of 35441 Da, which was 
heavier than expected by 20 Da.  The mass of 35441 is almost within the generally 
accepted error of 0.05% from the expected mass of 35421 Da.  Alternatively, the protein 
may have bound a sodium ion.  We had observed variable numbers of bound sodium ions 
in previous spectra of SiaA from our laboratory.  Replacement of a proton with a sodium 
ion increases the mass of the protein by 22 Da.   If the protein bound a sodium ion, the 
experimental and theoretical masses were very close (35441 – Na = 35419 and 35421, 
respectively).   
 
Calculation of holoprotein.  The experimental ratio of the peak at 409 nm to that at 280 
nm was 0.25 ± 0.04, showing that the apo- and holoprotein did not separate on the 
column (Figure 32).  Approximately 15% of the protein was found in the holo form.  
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Assuming an extinction coefficient of 1 x 105 M-1 cm-1 for the holoprotein at the Soret, 
0.88 mg of holoprotein was isolated, indicating that the total amount isolated was 5.9 mg.   
 
SiaA temperature stability.  Studies of the temperature stability of SiaA were planned.  
An initial practice run was performed with myoglobin to test the protocol (Figure 33 and 
34).  The UV-vis spectrum showed two peaks, at 280 (apo- and holoprotein) and 420 
(holoprotein) nm.  Myoglobin was stable up to 60 °C (Figure 33).  The protein started to 
denature, as shown by the shift in the position and intensity of the heme band, when the 
temperature reached 70 °C (Figure 34). 
 
SiaA thermal denaturation.  To test the non-linear curve fitting program, the following 
procedure was followed.  First, a theoretical data set was created in Excel by assigning 
numbers for the folded absorbance, folded slope, unfolded absorbance, unfolded slope, 
enthalpy, and melting temperature.  The expected extent of unfolding was calculated as a 
function of temperature (Figure 35).  These theoretical values were then fitted using 
Kaleidagraph and the same equation.  In general, one person created the theoretical data 
and a second person fit the data. 
Kaleidagraph fitted values for all variables were then compared with theoretical 
values.  Several trials and errors were carried out until Kaleidagraph values and 
theoretical values matched.  These trials helped solve programming errors.   
It was desired to run a thermal denaturation of H229A SiaA.  This sample was 
15% holoprotein and 85% apo-protein.  When the experiment was attempted, an increase, 
rather than a decrease in absorbance was observed.  The sample after heating was opaque.  
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It was assumed that the apoprotein had denatured, leading to the opaqueness of the 
sample.   
It was hoped that it would be possible to perform a thermal denaturation of SiaA, 
even with a substantial fraction of apoprotein, if the experiment could be done at a very 
low absorbance of the holoprotein.   It was desired to test a sample with an absorbance of 
0.1 at 409 nm.  A concentrated myoglobin sample was prepared with an OD409 of 1.041 
(Figure 36).  Appropriate dilutions gave a sample with an OD409 of 0.109 (Figure 34). 
Denaturation was run by heating the sample from at 25 °C to 95 °C at 0.5 °C per 
min (Figure 37).  The sample had the pH 7.11 and a height of 3.5 cm before denaturation 
and pH 7.19 and a height of 2.7 cm after denaturation.  Over the course of the 
experiment, the height of the sample decreased 0.8 cm and the pH increased by 0.09.  The 
sample had OD409 of 0.187 after denaturation (Figure 38).  Evaporation of the sample 
presumably led to an increase in concentration by a factor of 1.29.  This increase in 
concentration was presumably not linear over the course of the experiment, and therefore 
was not taken into account in the data fitting. 
Non-linear least squares fitting of the data to the relevant equation (Figure 35) 
was performed with Kaleidagraph.  Initially, one makes estimates of values for the six 
relevant variables.  These were, yn (m1) = 0.9, mn (m2) = -0.0001518 abs/°C, yu (m3) = 
0.02125, mu (m4) = 0.0001086 abs/°C, ΔH (m5) = 10000 J, and Tm (m6) = 78 °C.  A 
series of input parameters with numerical values near these initial estimates were tried.  
The final 10 fitting runs are shown in Figure 39.  Various different sets of initial values 
gave very similar sets of fitted parameters (Figure 40).  The final error for each variable 
was less than 1%.  The melting point was 78.8 ± 0.1 °C and ΔH was 4611 ± 41 J.  The 
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melting point was consistent with previous findings of 75 °C by the Hildebrand group  
(Hildebrand et al., 1995). 
 
35 
Conclusions 
 
In this work, the H229 mutant of the heme binding protein SiaA was isolated.  
Growth of the organism, followed by French press to lyse the cells, and nickel affinity 
FPLC, gave the desired protein.  SDS-PAGE showed that pure H229A was isolated.  
Both ESI and MALDI mass spectrometry indicated a mass of 35441 Da, very close to the 
expected value of 35421 Da.  The protein may bind a sodium ion in the gas phase.  
Histidine 229 is likely to be an axial ligand in wild type SiaA; the mutant readily lost 
heme as evidenced by UV-visible spectra.  Calculations indicated that the protein was 
about 15% holo and 85% apo as isolated.  The assignment of H229 as the axial ligand is 
also consistent with computer threading studies of the structure with related proteins 
which bind heme, vitamin B12 and iron.  Preliminary studies on thermal denaturation of 
heme proteins were performed. 
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Figure 1.  Streptococcal iron acquisition gene cluster.   
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Figure 2.  The SiaA construct  (Bates et al, 2005).  The black band is the lipoprotein that 
was replaced with His-Tag (blue), Xpress epitope (green), and enterokinase (EK) (green) 
cleavage site, and additional residues (red).  The orange sequence shows the observed 
alternative EK cleavage site. 
 
6x His tag Xpress epitope EK 
 
   SiaA      
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDKDR-WGSELE 
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Figure 3.  Representative diagram of Sia ABC.  SiaA, bound to the plasma membrane, 
binds heme and carries it to SiaB, the permease, which transports heme to the inner 
membrane through SiaC, the ATPase system. 
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Figure 4.  B12-bound BtuF associating with BtuC2D2.  Reprinted from  (Locher et al, 
2004).  
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Figure 5.  An Isd system model displaying the cell wall linked proteins, IsdABCH, the 
transporter, IsdDEF, and the cytosolic proteins IsdGH.  Reprinted from  (Skaar et al, 
2004). 
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  1 MIKRCKGIGL ALMAFFLVAC VNQHPKTAKE TEQQRIVATS 
41  VAVVDICDRL NLDLVGVCDS KLYTLPKRYD AVKRVGLPMN  
81 PDIELIASLK PTWILSPNSL QEDLEPKYQK LDTEYGFLNL  
121 RSVEGMYQSI DDLGNLFQRQ QEAKELRQQY QDYYRAFQAK  
161 RKGKKKPKVL ILMGLPGSYL VATNQSYVGN LLDLAGGENV  
201 YQSDEKEFLS ANPEDMLAKE PDLILRTAHA IPDKVKVMFD  
241 KEFAENDIWK HFTAVKEGKV YDLDNTLFGM SAKLNYPEAL 
281 DTLTQLFDHV GDHP 
 
 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQHPKTAKET
EQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYDAVKRVGLPMNPDIELI
ASLKPTWILSPNSLQEDLEPKYQKLDTEYGFLNLRSVEGMYQSIDDLGNLFQRQQ
EAKELRQQYQDYYRAFQAKRKGKKKPKVLILMGLPGSYLVATNQSYVGNLLDL
AGGENVYQSDEKEFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDI
WKHFTAVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDHP]] 
 
 
Figure 6.  (Top) The sequence of wild type SiaA  (Bates et al, 2005).  (Bottom) The 
recombinant SiaA sequence  (Bates et al, 2005).  Enterokinase is expected to cleave at the 
red bracket (after DDDDK).  However, experiments showed that EK cleaved at both 
brackets.  The molecular weight of the entire construct is 35,618.  Within the red 
brackets, the apoprotein weighs 31,918 while the holoprotein weighs 32,534.  For the 
black brackets, the apoprotein weighs 32,189 while the holoprotein weighs 32,805.  The 
blue sequence at the N-terminus contains a His-Tag and Xpress epitope. 
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Figure 7.  Wild type SiaA was threaded into 1N4D (BtuF ligand unbound)  (Karpowich 
et al, 2003).  The His229, Met79, Tyr63, and Tyr179 residues are colored red, blue, 
yellow and yellow, respectively, and displayed using space filling models.  Data are from 
3D-Jigsaw, visualized with RasMol 2.7.2.2.1. 
Tyr179 
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Figure 8.  Wild type SiaA was threaded into 1N4A (BtuF ligand unbound)  (Karpowich 
et al, 2003).  The proposed His229 and Met79 residues are showed in red and blue, 
respectively.  Data are from LOOPP, visualized with RasMol 2.7.2.2.1. 
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Figure 9.  Wild type SiaA was threaded into 2CHU (CeuE ligand unbound)  (Muller et 
al, 2006).  The proposed His229 and Met79 residues are showed in red and blue 
respectively.   Data are from LOOPP, visualized with RasMol 2.7.2.2.1. 
48 
 
 
 
 
 
Figure 10.  Wild type SiaA was threaded into 1K7S (FhuD ligand unbound)  (Clarke et 
al, 2002a).  The proposed His229 and Met79 residues are showed in red and blue 
respectively.  Data are from LOOPP, visualized with RasMol 2.7.2.2.1. 
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SiaA 35  RIVATSVAVVDICDRLNLD--LVGVCDSKLYTL----PKRYDAVKRVGLPMNPDIELIASLKPTWI  94 
         RIV T+VA+    D+L+L   +VG   S   TL    P RY  V  +G PM P++E +  LKPT + 
IsdE 6   RIVPTTVALTMTLDKLDLP--IVGKPTS-YKTL----PNRYKDVPEIGQPMEPNVEAVKKLKPTHV  64 
         R++  S A  ++     +    VGV     Y      P +   +++V      ++E I +LKP  + 
BtuF 4   RVITLSPANTELAFAAGIT--PVGVSSYSDY------PPQAQKIEQVSTWQGXNLERIVALKPDLV  61 
         RIVA     V++   L +     GV D+  Y L    P   D+V  VGL   P++EL+  +KP+++ 
FhuD 4   RIVALEWLPVELLLALGIV--PYGVADTINYRLWVSEPPLPDSVIDVGLRTEPNLELLTEMKPSFM  70 
         ++V   + ++D  D L L+  +VGV    L        +++     VG     D E I +LKP  I 
CeuE 38  KVVILDLGILDTFDALKLNDKVVGVPAKNLPKY----LQQFKNKPSVGGVQQVDFEAINALKPDLI  99 
 
 
 
 
PDB ID Name Identities (%) Positives (%) Gaps (%) 
2Q8Q IsdE 45 68 0 
2QI9 BtuF 20 45 2 
1EFD FhuD 25 43 11 
2CHU CeuE 22 42 8 
 
 
Figure 11.  (Top) Sequence alignment between SiaA and IsdE, BtuF, CeuE, and FhuD  
from PSI-Blast and PHI-Blast.  (Bottom) Percent identities, positives, and gaps between 
SiaA sequence and IsdE, BtuF, FhuD, and CeuE sequences.  IsdE has highest percentage 
of identities, positives, and lowest percentage of gap to SiaA. 
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Figure 12.  Nickel affinity FPLC chromatogram performed on French pressed, 
centrifuged, and filtered supernatant from the 2 L run.  The dotted line starting at fraction 
10 indicates a linearly increasing concentration of elution buffer (binding buffer with 0.5 
M imidazole).  SiaA elutes at approximately 0.1 M imidazole.  Fractions 15-31 were 
collected. 
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H229A UV-vis spectrum after FPLC PNI17 Nov.6-2006
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Figure 13.  The UV-vis spectra of the fractions from Figure 11.  The fraction with the 
greatest amount of heme (420 nm) appears to be F28, indicating that the last of the peaks 
eluted is the holoprotein.   
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Figure 14.  SDS-PAGE of nickel affinity FPLC fractions 16, 18, 21, 25, 26, 27, 29, 30, 
and 31 from 2 L run (Figure 11).  The MW lane contains the Precision Plus Protein® 
molecular weight marker standard.  Fractions 26, 27, and 29 show a solid band at 
approximately 37 kDa. 
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Figure 15.  Anion exchange FPLC chromatogram using a HiTrap Q HP (5 mL) column 
of fractions 25 to 31 from the nickel affinity purification.  The green dotted line indicates 
a linearly increasing concentration of NaCl in the elution buffer.  The data was saved in 
two files, fractions 1-27 and then (renumbering 28 as 1) fractions 1-14 (Figure 15).  The 
elution buffer started at fraction 15.  Fractions 21, 23, and 25 (containing the three small 
peaks) were collected.
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Figure 16.  Anion exchange FPLC chromatogram using a HiTrap Q HP (5 mL) column 
of fractions 25 to 31 from the nickel affinity purification.  This is a continuation of data 
from Figure 14.  The green dotted line indicates a linearly increasing concentration of 
NaCl in the elution buffer.  The NaCl concentration at the start of the chromatogram was 
0.4 M.  The NaCl concentration in the elution buffer was 1.0 M.  The peak at 30.85 min 
eluted at 0.77 M NaCl.  
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Figure 17.  Nickel affinity FPLC chromatogram performed on French pressed, 
centrifuged, and filtered supernatant from the 3 L run.  The dotted line starting at fraction 
11 indicates a linearly increasing concentration of elution buffer (binding buffer with 0.5 
M imidazole).  SiaA is found in fractions 28 – 34.  It elutes at approximately 0.12 M 
imidazole.  Fractions 15 - 35 were collected. 
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Figure 18.  The spectra of fractions 17-22 from the nickel affinity column in Figure 16.  
The leading edge of the peak has heme; the trailing edge does not appear to contain 
heme.  SDS PAGE (Figure 19) shows that these fractions have a number of proteins.  
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H229A FPLC Ni Affinity F28-33 PNI34 3-15-2007
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Figure 19.  The spectra of fractions 27 – 33.  The peaks at 420 nm showed that these 
fractions contain holoprotein.  The fact that the peak at 280 nm is larger than that at 420 
nm indicates that these are a mixture of apo- and holoprotein (pure holoprotein has a 
420/280 ratio of approximately 1.67 (Sook, unpublished).  The fact that the 420/280 ratio 
of all the fractions is approximately 0.21 to 0.30 indicates that the apo- and holoproteins 
are not separating on the column. 
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Figure 20.  SDS-PAGE of nickel affinity FPLC fractions 18, 19, 22, 23, 24, 25, and 26 
from 3 L run (Figure 16).  The MW lane contains the Precision Plus Protein® molecular 
weight marker standard.  All fractions contained some contaminant proteins; fractions 23, 
25, and 26 are the purest. 
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Figure 21.  SDS-PAGE of nickel affinity FPLC fractions 27 to 35 from the 3 L run 
(Figure 16).  The MW lane contains the Precision Plus Protein® molecular weight 
marker standard.  Fractions 30, 31, and 32 showed one solid band. 
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Figure 22.  SDS-PAGE of nickel affinity FPLC fractions 32 and 33 from the 3 L run 
(Figure 16).  The MW lane contains the Precision Plus Protein® molecular weight 
marker standard.  Fractions 32 and 33 showed one solid band. 
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Figure 23.   MALDI  mass spectrum of fraction 32 from Figure 20.  The tallest peak is at 
35441 Da.  The spectrum indicates that the sample is very salty.    
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Figure 24.  ESI mass spectrometry of fraction 32 from Figure 20.  The tallest peak is at 
35441.0 Da.  The spectrum indicates that the sample is very salty.   
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Wild type (WT) SiaA Sequence Molecular 
Weight (Da) 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRY
DAVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYG
FLNLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKR
KGKKKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEK
EFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFT
AVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDHP]] 
 
 
35618.2 
_GGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRY
DAVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYG
FLNLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKR
KGKKKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEK
EFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFT
AVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDHP]] 
 
 
35487.0 
__GSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRY
DAVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYG
FLNLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKR
KGKKKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEK
EFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFT
AVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDHP]] 
 
 
35430.0 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRY
DAVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYG
FLNLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKR
KGKKKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEK
EFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFT
AVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDH_]] 
 
 
35521.1 
_GGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRY
DAVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYG
FLNLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKR
KGKKKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEK
EFLSANPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFT
AVKEGKVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGD_]] 
 
35389.9 
 
Figure 25: The molecular weight of WT SiaA, SiaA – Met, SiaA – (Met + Gly), SiaA – 
Pro, and SiaA – (Met + Pro). 
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Mutant SiaA (H229A) Sequence Molecular 
Weight (Da) 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYD
AVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYGFL
NLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKRKGK
KKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEKEFLSA
NPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFTAVKEG
KVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDAP]] 
 
 
35552.2 
_GGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQH
PKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYDA
VKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYGFLN
LRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKRKGKK
KPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEKEFLSAN
PEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFTAVKEGK
VYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDAP]] 
 
 
35421.0 
__GSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQH
PKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYDA
VKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYGFLN
LRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKRKGKK
KPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEKEFLSAN
PEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFTAVKEGK
VYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDAP]] 
 
 
35363.9 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQ
HPKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYD
AVKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYGFL
NLRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKRKGK
KKPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEKEFLSA
NPEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFTAVKEG
KVYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDA_]] 
 
 
35455.0 
_GGSHHHHHHGMASMTGGQQMGRDLYDDDDK[DR[WGSELEVNQH
PKTAKETEQQRIVATSVAVVDICDRLNLDLVGVCDSKLYTLPKRYDA
VKRVGLPMNPDIELIASLKPTWILSPNSLQEDLEPKYQKLDTEYGFLN
LRSVEGMYQSIDDLGNLFQRQQEAKELRQQYQDYYRAFQAKRKGKK
KPKVLILMGLPGSYLVATNQSYVGNLLDLAGGENVYQSDEKEFLSAN
PEDMLAKEPDLILRTAHAIPDKVKVMFDKEFAENDIWKHFTAVKEGK
VYDLDNTLFGMSAKLNYPEALDTLTQLFDHVGDA_]] 
 
 
35323.8 
 
Figure 26.  The molecular weight of mutant SiaA, H229A – Met, H229A – (Met + Gly), 
H229A – Pro, and H229A – (Met + Pro). 
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  SiaA (Da) 
SiaA - Met  
(Da) 
SiaA - (Met + Gly)  
(Da) 
SiaA – Pro 
 (Da) 
SiaA - (Met + Pro) 
 (Da) 
WT SiaA  35618 35487 35430 35521 35390 
H229A 35552 35421 35364 35455 35324 
            
F33 (Da) 
35441 
± 0.056 %   
MALDI error 
(0.05%) (Da) ± 17    
Na + (Da) 22   
 ESI error  
(0.02%) (Da) ± 7    
 
 
Figure 27.  The expected molecular weight (MW) of H229A is 35552.3 Da.  The actual 
MW of mutant SiaA (H229A – Met) is 35421 Da. The MW of fraction 33, H229A, is 
35441 Da.  It is heavier than the H229A – Met by 20 Da, which is close to the MW of a 
sodium ion. 
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Figure 28.  MALDI mass spectrometry of fraction 32 after desalting.  The tallest peaks 
are at 35386.6 Da and 35589.6 Da.  Both molecular weights are heavier than that 
observed in the saltier sample (Figure 22).  The theoretical weight of H229A SiaA is 
35552.2. 
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Figure 29.  Close-up of the major peak from Figure 24. 
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Figure 30.   MALDI mass spectrum of fraction 33 from Figure 21.  The tallest peak is at 
35441 Da.  Carbonic anhydrase was used for internal standard.   
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Figure 31.  MALDI mass spectrometry of fraction 33 after desalting.  The tallest peak is 
at 35526.5 Da.  The molecular weight is heavier than the salting sample. 
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  Abs Abs         
Fraction 280 nm 409 nm 
Experimental 
ratio 
Fraction 
holo [Holo] grams 
27 0.55 0.12 0.22 0.13 1.2E-06 8.5E-05 
28 0.55 0.12 0.22 0.13 1.2E-06 8.5E-05 
29 0.65 0.16 0.25 0.15 1.6E-06 1.1E-04 
30 0.85 0.25 0.29 0.18 2.5E-06 1.8E-04 
31 0.89 0.27 0.30 0.18 2.7E-06 1.9E-04 
32 0.73 0.20 0.27 0.16 2.0E-06 1.4E-04 
33 0.57 0.12 0.21 0.13 1.2E-06 8.5E-05 
    Avg 0.25 0.15   8.8E-04 
    SD 0.039       
Assumes that each fraction is 2.0 mL,      
that the extinction coefficient at the Soret is 1 x 105 M-1 cm-1   
and the 409/280 nm ratio for holoprotein is 1.67    
The expected molecular weight of the protein is 35,552.   
Total protein 5.9 mg     
 
Figure 32.  Absorbances at 280 and 409 nm for fractions 27 - 33, allowing calculation of 
the fraction of holoprotein, the molarity of holoprotein, and the weight of holoprotein for 
each fraction.  Totals are also given.  
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Figure 33.  Horse heart myoglobin in phosphate buffer as a function of temperature.  The 
temperature was held at each point for 2 h.  The temperature was increased during the 
run.  The Soret band increases as the temperature increases up to 60 °C in this 
experiment.   
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Figure 34.  Horse heart myoglobin in phosphate buffer as a function of temperature.  The 
temperature was held at each point for 2 h.  The temperature was increased during the 
run.  When the sample was kept at 70 °C for 2 h, the Soret band decreased in intensity.  A 
further decrease was seen on heating to 80 °C. 
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yobs = (m1+m2*m0)+(m3+m4*m0)*(exp((m5/1.987)*((1/m6)-(1/m0)))) 
(1+exp((m5/1.987)*((1/m6)-(1/m0)))) 
 
Figure 35.  (Top) Thermal denaturation equation  (Swint & Robertson, 1993).  (Bottom) 
Thermal denature equation defined in Kaleidagraph.  The experimental absorbance is 
yobs.  T (m0) is the temperature in Celsius; R is the gas constant (R = 1.987 (J/(mol*K));  
ΔHm (m5) is the enthalpy; and Tm (m6) is the melting temperature.  The y-intercepts of 
the folded and unfolded baselines are yn (m1) and yd (m3), respectively.  The slopes of 
the baselines are mn (m2) and md (m4), respectively. 
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Figure 36.  Equine skeletal muscle myoglobin in phosphate buffer.  At OD409, the 
absorbance for the original sample, 1:3 dilution, and 1:0 dilution are 1.04, 0.34, and 0.11, 
respectively. 
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Figure 37.  The absorbance at 409 nm of equine skeletal muscle myoglobin in 50 mM, 
pH 7.1 phosphate buffer as a function of temperature.   
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Figure 38.  The absorbance of equine skeletal muscle myoglobin in 50 mM phosphate 
buffer, pH 7.1 at room temperature after thermal denaturation. 
77 
 
Trial 
m1  
(native) 
 
(abs) 
m2  
(folding  
slope) 
(abs/°C) 
m3  
(unfolding) 
 
(abs) 
m4  
(unfolding  
slope) 
(abs/°C) 
m5  
(ΔH) 
 
(J) 
m6  
(melting 
 temp) 
(°C) 
1 0.9 -0.0001518 0.02125 0.0001086 10000 78 
2 0.91 -0.0001518 0.02125 0.0001086 8000 78 
3 0.91 -0.0001618 0.022 0.0001086 8000 78.5 
4 0.91 -0.0001718 0.0225 0.0001086 7000 78.5 
5 0.91 -0.0001818 0.03 0.0001086 7000 78.8 
6 0.91 -0.0001818 0.015 0.0001086 4600 78.8 
7 0.95 -0.00018 0.01 0.0001086 4600 78.8 
8 0.95 -0.00018 0.005 0.0001086 4600 78.8 
9 0.95 -0.00018 0.0001 0.0001086 4600 78.8 
10 0.95 -0.00018 0 0.0001086 4600 78.8 
 
Trials 
m1  
(native) 
 
(abs) 
m2 
 (folding 
slope) 
(abs/°C) 
m3  
(unfolding) 
 
(abs) 
m4  
(unfolding 
slope) 
(abs/°C) 
m5  
(ΔH) 
 
(J) 
m6  
(melting  
temp) 
(°C) 
R 
 
 
1 
0.108  
±5.466e-4 
-0.000420  
±1.067e-5 
0.0238  
±7.428e-3 
0.0000510 
 ±8.339e-5 
9735  
±557 
78.3  
±0.05 0.99052 
2 
0.0951 
 ±1.169e-4 
-0.000177 
 ±2.401e-6 
-0.0320  
±3.056e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8 
    ±0.05 0.99964 
3 
0.0951 
 ±1.169e-4 
-0.000177 
 ±2.401e-6 
-0.0320 
 ±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8  
±0.05 0.99964 
4 
0.0951  
±1.169e-4 
-0.000177  
±2.401e-6 
-0.0320  
±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8 
 ±0.05 0.99964 
5 
0.0951 
 ±1.169e-4 
-0.000177  
±2.401e-6 
-0.0322  
±3.055e-3 
0.000650 
 ±3.311e-5 
4609  
±41 
78.8  
±0.05 0.99964 
6 
0.0951  
±1.169e-4 
-0.000177  
±2.401e-6 
-0.0322  
±3.055e-3 
0.000650 
 ±3.314e-5 
4609  
±41 
78.8  
±0.05 0.99964 
7 
0.0951  
±1.169e-4 
-0.000177 
 ±2.401e-6 
-0.0320  
±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8  
±0.05 0.99964 
8 
0.0951 
 ±1.169e-4 
-0.000177  
±2.401e-6 
-0.0320  
±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8  
±0.05 0.99964 
9 
0.0951 
 ±1.169e-4 
-0.000177  
±2.401e-6 
-0.0320  
±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8  
±0.05 0.99964 
10 
0.0951 
 ±1.169e-4 
-0.000177  
±2.401e-6 
-0.0320  
±3.053e-3 
0.000648 
 ±3.311e-5 
4611  
±41 
78.8  
±0.05 0.99964 
AVG 
0.0951 
 ±1.169e-4 
-0.000177  
±2.401e-6 
-0.0321  
±3.053e-3 
0.000649 
 ±3.312e-5  
4611  
±41 79 ±0.1 0.99964 
 
 
Figure 39.  Kaleidagraph data fitting. (Top) For each trial, the value for each variable 
was estimated and put into thermal denaturation equation (Figure 37). The fitted values 
are shown in the lower half of the table.
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Figure 40.  Kaleidagraph curve fit for Trial 10. 
 
 
 
